Table 2. Preoperative laboratory data findings.
| Case | WBC (cells × 109 L) | Neut (%) | RBC (×106) | Hgb (g/dL) | Hct (%) | Plt (×1000/μL) | PT (s) | APTT (s) | FDP (μg/mL) | Fibg (mg/dL) | D-dimer (μg/mL) | CEA (ng/mL) | SCC (ng/mL) | CYFRA (ng/mL) | ProGRP (pg/mL) | NSE (ng/mL) | pCO2 (mmHg) | pO2 (mmHg) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 3.6 | 55.2 | 4.77 | 15.6 | 45.5 | 209 | 12.1 | 36.6 | – | 199 L | – | 2.3 | 1 | 1.2 | 46.3 | 12.8 H | 46.5 H | 93.6 |
| 2 | 4.8 | 57.1 | 3.93 | 11.4 L | 34.6 L | 408 H | 10.8 | 29.6 | <2.6 | 203 | <0.32 | 0.9 L | N/A | 0.6 | N/A | N/A | 36.5 | 84.4 L |
| 3 | 5.6 | 50.3 | 4.57 | 16 | 45.8 | 130 L | 11.3 | 26.0 L | 3.5 | 200 | 1.71 H | 3.8 | 1.6 | 1.9 | 87.2 H | 10.3 | 38.7 | 91.3 |
| 4 | 8.2 | 71.5 | 3.82 L | 11.7 L | 35.5 L | 253 | 9.8 L | 30.2 | <2.6 | 230 | 0.43 | 2.1 | 1 | 3.2 | 36.8 | 10 | 46.2 H | 94.4 |
APTT: activated partial thromboplastin time; CEA: carcinoembryonic antigen; CYFRA: cytokeratin fragment; FDP: fibrin degradation product; Fibg: fibrinogen; Hct: hematocrit; Hgb: hemoglobin; Neut: neutrophil; NSE: neuron specific enolase; pCO2: partial pressure of arterial carbon dioxide; Plt: platelet; pO2: partial pressure of arterial oxygen; ProGRP: pro-gastrin- releasing peptide; PT: prothrombin time; RBC: red blood cell; SCC: squamous cell carcinoma antigen; WBC: white blood cell